Ticker Symbol: PTCT
PTC Therapeutics Inc
$40.33 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001070081
Company Profile
PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and its mission to provide access to best-in-class treatments for patients who have an unmet medical need. The Company's strategy is to leverage its strong scientific expertise and global commercial infrastructure to maximize value for its patients and other stakeholders.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 100 Corporate Ct
Website: www.ptcbio.com
CEO: Stuart Peltz
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $20.43
Change:
-$0.81
(
-3.81%)
Days Range: $20.39 - $21.35
Beta: 0.77
52wk. High: $59.84
52wk. Low: $19.70
Ytd. Change -48.17%
50 Day Moving Average: $27.08
200 Day Moving Average: $40.78
Shares Outstanding: 75344951
Valuation
Market Cap: 153.9B
PE Ratio: -2.42
EPS (TTM): -8.44
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A